Spontan - I used it!, page-29

We should see the following by then, at least:
- final results (actually within a week or two) making global news
- more prescribers added to the network and ramping up of sales under TGA early access (though sales will still be limited given it's still not the same as full approval market penetration)
- FDA and TGA pre approval meetings update
- announcement of further indication for trial

That being said, and at the current rate, may be $2.50 or less? No idea. Actually easier in some respects to place predictions for around late 2025 given 2025 is the major catalyst year.